Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Oct 15;56(4):2001935.
doi: 10.1183/13993003.01935-2020. Print 2020 Oct.

Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study

Stefano Aliberti  1   2 , Dejan Radovanovic  3 , Filippo Billi  4 , Giovanni Sotgiu  5 , Matteo Costanzo  2 , Tommaso Pilocane  1   2 , Laura Saderi  5 , Andrea Gramegna  1   2 , Angelo Rovellini  4 , Luca Perotto  3   6 , Valter Monzani  4 , Pierachille Santus  3   6 , Francesco Blasi  1   2
Affiliations
Observational Study

Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study

Stefano Aliberti et al. Eur Respir J. .

Abstract

Helmet CPAP treatment fails in up to 44% of patients with moderate-to-severe hypoxaemic acute respiratory failure due to COVID-19 pneumonia https://bit.ly/3g7FAB8

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: S. Aliberti reports grants and personal fees from Bayer Healthcare, Aradigm Corporation, Grifols, Chiesi and INSMED, personal fees from AstraZeneca, Basilea, Zambon, Novartis, Raptor, Actavis UK Ltd and Horizon, outside the submitted work. Conflict of interest: D. Radovanovic has nothing to disclose. Conflict of interest: F. Billi has nothing to disclose. Conflict of interest: G. Sotgiu has nothing to disclose. Conflict of interest: M. Costanzo has nothing to disclose. Conflict of interest: T. Pilocane has nothing to disclose. Conflict of interest: L. Saderi has nothing to disclose. Conflict of interest: A. Gramegna has nothing to disclose. Conflict of interest: A. Rovellini has nothing to disclose. Conflict of interest: L. Perotto has nothing to disclose. Conflict of interest: V. Monzani has nothing to disclose. Conflict of interest: P. Santus has nothing to disclose. Conflict of interest: F. Blasi reports grants and personal fees from AstraZeneca, Chiesi, GSK, Insmed and Pfizer, grants from Bayer, personal fees from Guidotti, Grifols, Menarini, Mundipharma, Novartis, Zambon and Vertex, outside the submitted work.

References

    1. Cosentini R, Brambilla AM, Aliberti S, et al. . Helmet continous positive airway pressure vs oxygen therapy to improve oxygentaion in community-acquires pneumonia: a randomized controlled trial. Chest 2010; 138: 114–120. doi:10.1378/chest.09-2290 - DOI - PubMed
    1. Brambilla AM, Aliberti S, Prina E, et al. . Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia. Intensive Care Med 2014; 40: 942–949. doi:10.1007/s00134-014-3325-5 - DOI - PubMed
    1. Vitacca M, Nava S, Santus P, et al. . Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches. Eur Respir J 2020; 55: 2000632. - PMC - PubMed
    1. Ferioli M, Cisternino C, Leo V, et al. . Protecting healthcare workers from SARS-CoV-2 infection: practical indications. Eur Respir Rev 2020; 29: 200068. doi:10.1183/16000617.0068-2020 - DOI - PMC - PubMed
    1. Radovanovic D, Rizzi M, Pini S, et al. . Helmet CPAP to treat acute hypoxemic respiratory failure in patients with COVID-19: a management strategy proposal. J Clin Med 2020; 9: E1191. doi:10.3390/jcm9041191 - DOI - PMC - PubMed

MeSH terms